Minerva Neurosciences (NERV) Stock Statistics & Valuation Metrics

Minerva Neurosciences has a market cap or net worth of $25.67M. The enterprise value is $57.67M.

Minerva Neurosciences has 6,993,406 shares outstanding. The number of shares has decreased by -2.65% in one year.

Minerva Neurosciences’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -63.68%.

The current PE Ratio of Minerva Neurosciences is 2.5. Minerva Neurosciences’s PEG ratio is -0.11.

In the last 12 months, Minerva Neurosciences had revenue of 0.00 and earned 1.44M in profits. Earnings per share was 0.19.

In the last 12 months, operating cash flow was -9.03T and capital expenditures 0.00, giving a free cash flow of -9.03T billion.

Minerva Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Minerva Neurosciences upcoming earnings date is Mar 10, 2026, TBA (Confirmed).

Minerva Neurosciences as a current ratio of 7.85, with Debt / Equity ratio of -186.86%

In the past 12 months, Minerva Neurosciences has paid 0.00 in taxes.

Minerva Neurosciences EV to EBITDA ratio is 9.20, with an EV/FCF ratio of -2.84.

Minerva Neurosciences has $12.29T in cash and marketable securities with $0.00 in debt, giving a net cash position of $12.29T billion.

Gross margin is 30.25%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Minerva Neurosciences is $4.00, which is 11.43% higher than the current price. The consensus rating is Hold